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Abstract In Saccharomyces cerevisiae, the overexpression of
ROD1 confers resistance to o-dinitrobenzene (o-DNB), a repre-
sentative of target drugs of glutathione S-transferase. The roles
of Rod1 in drug resistance have remained to be determined. We
isolated the rog3 mutation as a suppressor mutation of the
temperature sensitivity of the strain, in that two of the total
four glycogen synthase kinase 3 homologs were deleted. Rog3
is homologous to Rod1, and its overexpression also conferred
resistance to o-DNB. Furthermore, these two proteins have PY-
motifs, and bound to Rsp5, a hect-type ubiquitin ligase. The
rsp5-101 mutant showed sensitivity to o-DNB as did the rod1
mutant, a mutant Rod1 containing altered PY motifs was de-
fective in ability to bind to Rsp5 and in conferring o-DNB re-
sistance. These results suggest that interaction of Rod1 and
Rsp5 is important for drug resistance. - 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Treatment of humans with tumors can be hampered by the
resistance of cancer cells to a broad range of cytotoxic drugs.
Using the yeast Saccharomyces cerevisiae, an excellent model
for studying mammalian multi-drug resistance, a large num-
ber of genes mediating the resistance to toxic drugs has been
identi¢ed. Proteins encoded by these genes are divided gener-
ally into two main groups. One consisting of membrane ATP-
binding cassette (ABC) transporter proteins such as Pdr5,
Snq2, Ycf1, and Yor1, and the other regulatory factors such
as Pdr1, Pdr3, Pdr13, Ngg1, Yrr1, yAP1, and Cmk1, which
control these transporters at transcriptional or the post-trans-
lational levels (reviewed in [1]).
In eukaryotic cells, a large number of lipophilic toxins is
conjugated with glutathione, often by the glutathione S-trans-
ferase (GST) enzyme. Toxic drugs covalently conjugated with
glutathione are recognized and eliminated from the cytosol by
the GS-X (glutathione S-conjugate transporting ATPase)
pump. In S. cerevisiae, Ycf1, a vacuolar membrane-bound
GS-X pump, transports GS-conjugates from the cytosol to
the vacuole. The ycf1 disruptant shows higher sensitivity to
1-chloro-2,4-dinitrobenzene (CDNB), one of the substrates of
the GST enzyme [2]. In research done on the detoxi¢cation
pathway involving the glutathione-conjugating system, ROD1
was found to confer resistance to o-dinitrobenzene (o-DNB),
another substrate of the GST enzyme [3]. The ROD1-overex-
pressed cell shows resistance to o-DNB, and the rod1 disrup-
tant shows sensitivity to o-DNB. Rod1 is co-fractionated at
the plasma membrane [3], however, as deduced by its primary
amino acid sequence, it is not likely that Rod1 is a member of
the ABC transporter proteins. Whether Rod1 regulates trans-
porters has not been determined nor have its functions been
elucidated [3].
Rsp5 is an essential hect-type ubiquitin ligase and plays
roles in several cellular functions involving protein degrada-
tion and transcriptional regulation [4^6]. Rsp5 has three WW
domains. The WW domain is known to bind to the PY motif
[7], and the PY-motif-containing proteins Bul1 and Bul2 are
reported to bind to Rsp5 and may promote functions of Rsp5
in protein degradation [5,8]. However, factors other than Bul1
and Bul2 have never been found to regulate Rsp5 functions.
S. cerevisiae has four genes, MCK1, MDS1/RIM11, MRK1,
and YOL128c, which encode homologs of mammalian GSK-
3. GSK-3s of S. cerevisiae act in the transcriptional regulation
of meiotic genes [9^11], the chromosomal segregation process-
es at mitosis [12], and the cell cycle delay by the addition of
Ca2þ [13]. In an earlier study, we identi¢ed ¢ve exogenous
mutations, rog1^rog5, as suppressor mutations of the temper-
ature sensitivity of the mck1 mds1 mutant. Rog1 was de-
graded dependently on Rsp5 and GSK-3 [5], indicating that
Rsp5 functionally interacts with GSK-3. Rog3, isolated from
another suppressor mutation of the mck1 mds1 mutant, is
homologous with Rod1.
We now report on Rog3 and its homolog Rod1. Both Rog3
and Rod1 have two PY motifs and interact with Rsp5. Fur-
ther, a mutant Rod1, which decreases its binding ability to
Rsp5, does not confer resistance to o-DNB. Our ¢nding sug-
gests the involvement of Rsp5 and the importance of the
interaction between Rsp5 and Rod1 in drug resistance.
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2. Materials and methods
2.1. Materials and chemicals
pTS010, pTS011, pTS012 [14], and functional RSP5 plasmids,
pHY22 (myc-Rsp5) and YCp-HA-RSP5, were kindly provided by
Dr. Y. Kikuchi (University of Tokyo). GST fusion proteins and mal-
tose-binding protein (MBP) fusion proteins were puri¢ed from Esche-
richia coli according to the manufacturer’s instructions. Other materi-
als and chemicals were obtained from commercial sources.
2.2. Strains and genetic manipulations
S. cerevisiae strains used in this study were KA31a (wild type),
YTA002K (mck1: :TRP1 mds1: :HIS3), YAT2-1C (rsp5-101),
W303a (wild type) [5], YTA021K (MATa his3 leu2 ura3 trp1
mck1: :TRP1 mds1: :HIS3 rog3: :LEU2), and YTA122K (MATa
his3 leu2 ura3 trp1 rod1). Media and methods for mating, sporulation,
tetrad analysis, and transformation were as described [15].
2.3. Plasmid constructions
To construct pTA054 (pKT10-HA-Rog3), the hemagglutinin (HA)-
tagged EcoRI^SalI PCR fragment of ROG3 was inserted between the
EcoRI and SalI sites of pKT10 [5]. pTA055 (pKT10-HA-Rog3QA)
was prepared from pTA054 by replacing sequences 5P-CCCCCA-3P
(nucleotides +1378 to +1383) and 5P-CCTCCT-3P (nucleotides
+1873 to +1878) with 5P-CAGGCC-3P. pTA061 (YEplac195-Rod1^
HA) and pTA062 (YEplac112-Rod1^HA) were constructed by insert-
ing the SalI^SmaI PCR fragment of nucleotides 3771 to +2510
of ROD1 into the SalI and SmaI sites of pTS011 and pTS012 [14],
respectively. pTA063 (YEplac195-Rod1QA^HA) and pTA064
(YEplac112-Rod1QA^HA) were prepared from pTA061 and
pTA062, respectively, by replacing sequences 5P-ACCTCCC-3P (nu-
cleotides +1458 to +1464) and 5P-TCCACCGGC-3P (nucleotides
+1965 to +1973) with 5P-ACAGGCC-3P and 5P-TCAGGCCGC-3P,
respectively.
In pTA057 (rog3: :LEU2), nucleotides +52 to +2035 of ROG3 were
replaced by LEU2. To create pTA066 (rod1: :URA3), nucleotides +1
to +2551 of ROD1 were replaced by the 2.4-kb HindIII fragment of
TAp700 [5]. For expression of fusion proteins in E. coli, pTA063 was
constructed by inserting the 0.7-kb XbaI fragment of ROG3 into the
multi-cloning site of pGEX-KG.
2.4. Disruption of ROG3 and ROD1
Cells were transformed by pTA057 cut with DraI or by pTA066 cut
with SacI and SalI, and disruption of the ROG3 gene of Leuþ trans-
formants or disruption of the ROD1 gene of Uraþ transformants was
con¢rmed by Southern blotting analysis. For pop-out of the URA3
gene, rod1: :URA3 cells were incubated on a synthetic complete me-
dium plate containing 0.1% 5-£uoro-orotic acid and the colonies
formed were obtained.
2.5. Immunoblot analysis and immunoprecipitation
Exponentially growing yeast cells in 25 ml medium were collected
by centrifugation, washed once with lysis bu¡er (50 mM Tris^HCl,
pH 7.5, 0.3 M mannitol, 0.1 M KCl, 1 mM EGTA) containing 1 mM
phenylmethylsulfonyl £uoride, 1 Wg/ml antipain, 1 Wg/ml aprotinin,
1 Wg/ml leupeptin, and 1 Wg/ml pepstatin A [16], and resuspended in
100 Wl of ice-cold lysis bu¡er. The cells were broken by vortex mixer
with glass beads for 5 min at 4‡C. Then, 100 Wl of lysis bu¡er was
added, the homogenate was mixed vigorously, then was centrifuged at
14 000Ug for 5 min. The supernatant was recovered and centrifuged
at 14 000Ug for 5 min, and the resultant supernatant fraction served
as cell lysates which were probed with anti-HA and anti-myc anti-
bodies [17]. For the immunoprecipitation assay, the lysates were in-
cubated with the anti-HA antibody and protein A^Sepharose, then
precipitated by centrifugation. The immunoprecipitates were washed
¢ve times with the lysis bu¡er.
2.6. Other procedures
Nucleotide sequences were determined using Thermo Sequenase
pre-mixed cycle sequencing kits (Amersham Pharmacia Biotech,
Uppsala, Sweden). Southern hybridization was done as described
[18].
3. Results
3.1. Rog3 has PY motifs
In foregoing work, we obtained ¢ve insertional mutations
(named rog1^rog5) that suppressed temperature sensitivity of
the mck1 mds1 double null mutant [5]. Among the ¢ve, sup-
pression by the rog3 mutation was weak. Sequence analysis
revealed that the LEU2 fragment is inserted just after nucle-
otide +302 of the YFR022W in the rog3 mutant. To con¢rm
that the suppression was caused by a loss of function of
ROG3, the open reading frame of ROG3 was deleted. Disrup-
tion of ROG3 also slightly suppressed temperature sensitivity
of the mck1 mds1 double null mutant (Fig. 1), as did the
originally isolated rog3 mutation. In screening and con¢rma-
tion steps for the suppression, we used the mck1 mds1 double
null mutant instead of the disruptant of all four GSK-3 genes,
since the double null mutant showed the same phenotypes as
the quadruple null mutant and was easier to use for genetic
analysis. Despite weakness of its suppression phenotype, we
continued to examine the rog3 mutant since ROG3
(YFR022W) encodes a protein with two PY motifs (Fig. 2A).
3.2. Rog3 binds to Rsp5
The PY motif of Bul1 was reported to be important for in
vivo complex formation with Rsp5 [19]. To determine if PY
motifs of Rog3 bind to Rsp5, the GST-tagged fragment, in-
cluding the PY motifs of Rog3 (GST-Rog3PY-(431^679)),
was puri¢ed from E. coli and incubated with MBP^Rsp5 or
MBP [5] immobilized to amylose resin. GST-Rog3PY-(431^
679) co-precipitated with MBP^Rsp5 but not with MBP (Fig.
2Ba), thereby suggesting that the PY motifs of Rog3 directly
bind to Rsp5. To examine an interaction of Rsp5 and Rog3,
cell lysates of wild-type strains expressing myc-Rsp5 (pHY22)
or HA^Rog3 (pKT10-HA-Rog3) were mixed, then immuno-
precipitated with the anti-HA antibody. myc-Rsp5 was de-
tected in the HA^Rog3 immune complex (Fig. 2Bb), which
suggested that Rog3 forms a complex with Rsp5.
3.3. Rog3 is a homolog of Rod1
Rog3 shares 43% identity with Rod1. Since overexpression
Fig. 1. Deletion of ROG3 weakly suppressed temperature sensitivity
of the vmck1 vmds1 null mutant. Cells of KA31a (WT), YTA002K
(vmck1 vmds1), and YTA021K (vrog3 vmck1 vmds1) were incuba-
ted on a YPD plate for 2 days at 37‡C.
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of ROD1 was reported to confer resistance to o-DNB [3], we
asked if ROG3 would show a similar phenotype. Overexpres-
sion of ROG3 by pKT10-HA-Rog3, in which HA-tagged
Rog3 was expressed from TDH3 promoter, conferred resis-
tance to o-DNB (Fig. 2C). Therefore, we considered that
Rog3 and Rod1 are functional homologs, although, unlike
the rod1 mutant, the rog3 mutant did not show o-DNB sensi-
tivity (data not shown). Since Rod1 has two PY motifs (Fig.
3A), possible physical interaction between Rod1 and Rsp5
was examined. Cells co-expressing myc-Rsp5 (pHY22) and
Rod1^HA (YEplac112-Rod1^HA) were lysed then immuno-
precipitated with the anti-HA antibody. myc-Rsp5 was de-
tected in the Rod1^HA immune complex (Fig. 3B), suggesting
that Rod1 forms a complex with Rsp5 in intact cells.
3.4. PY motifs of Rod1 are important for binding to Rsp5 and
for resistance to o-DNB
We examined whether Rod1 and Rog3 bind Rsp5 through
their PY motifs. Two PY motifs of Rod1, PPNY and PPAY,
were mutated to QANY and QAAY, respectively (Rod1QA).
The binding of myc-Rsp5 to Rod1QA^HA was signi¢cantly
reduced as compared with that to wild-type Rod1^HA (Fig.
3B). When the amounts of myc-Rsp5 bound to Rod1^HA or
Rod1QA^HA were quanti¢ed by NIH Image Software, the
binding of myc-Rsp5 to Rod1QA was reduced to less than
28% of that to Rod1. Two PY motifs of Rog3, PPNY and
PPSY, were mutated to QANY and QASY, respectively (HA^
Rog3QA). We also found the reduction in the binding activity
of Rog3QA (Fig. 2Bb). Its binding activity to Rsp5 was re-
duced to less than 22% of wild-type Rog3. This suggests that
the PY motifs of Rod1 and Rog3 are important for binding to
Rsp5. Furthermore, expression of Rod1^HA but not
Rod1QA^HA rescued the o-DNB sensitivity of rod1 cells
(Fig. 3C). This means that Rod1QA^HA is defective as to
resistance to o-DNB, whereas Rod1^HA is functional. As
this ¢nding suggested the involvement of Rsp5 in drug resis-
tance, we asked if Rsp5 is involved in the resistance to
o-DNB. To this end, we investigated the o-DNB sensitivity
of the rsp5-101 mutant that is known to show temperature
sensitivity [19]. This mutant was sensitive to o-DNB at the
Fig. 2. Rog3 bound to Rsp5. A: Schematic representation of Rog3
is shown. The PY motifs of Rog3 and the region fused to GST in
GST-Rog3PY-(431^679) are shown by black boxes and the solid
bars, respectively. B: Binding assay between Rog3 and Rsp5 was
done. The GST-Rog3PY-(431^679) puri¢ed from E. coli was incuba-
ted with MBP^Rsp5 or MBP immobilized to amylose resin at 4‡C
for 1 h, and the precipitates were probed using an anti-GST anti-
body (a). Lysates of cells expressing myc-Rsp5 (pHY22), HA^Rog3
(pKT10-HA-Rog3), or HA^Rog3QA (pKT10-HA-Rog3QA) were
mixed and immunoprecipitated with the anti-HA antibody. Lysates
and the precipitates were probed with an anti-myc and anti-HA
antibodies (b). C: Overexpression of Rog3 conferred o-DNB resis-
tance. KA31a cells with pKT10 vector or pKT10-HA-Rog3 were in-
cubated on a YPD plate with or without 500 WM o-DNB at 26‡C
for 4 days.
Fig. 3. Rod1 and Rsp5 physically interacted in vivo. A: Schematic
representation of Rod1 and Rod1QA is shown. B: myc-Rsp5 was
co-immunoprecipitated with Rod1^HA. Cell lysates of W303a cells
carrying pTA062 (Rod1^HA), pTA064 (Rod1QA^HA), or pTS012
with pHY22 (myc-Rsp5) were directly probed with an anti-myc or
an anti-HA antibody. The immunoprecipitates obtained with the
anti-myc antibody were probed using the same antibodies. C: Ex-
pression of ROD1 suppressed o-DNB sensitivity of the rod1 mutant.
rod1 mutant cells (YTA122K) with pTA061 (Rod1^HA), pTA063
(Rod1QA^HA), or pTS011 were incubated on a YPD plate with or
without 450 WM o-DNB at 26‡C for 4 days.
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non-restrictive temperature and expression of HA^Rsp5 in the
rsp5-101 mutant cells rescued the phenotype (Fig. 4). Taken
together, these results suggest that Rod1 and Rsp5 play a role
in tolerance to o-DNB and that the interaction of Rod1 and
Rsp5 is important for o-DNB resistance.
4. Discussion
The detoxi¢cation pathway dependent on glutathione-con-
jugation plays an important role in resistance to a large num-
ber of drugs (reviewed in [20]). Rod1 may be involved in this
pathway as its overexpression confers resistance to o-DNB [3].
We found that Rog3, a Rod1 homolog, genetically interacted
with GSK-3 and that both Rog3 and Rod1 have two PY
motifs. Since GSK-3 functionally interacts with Rsp5 [5], a
functional interaction between Rog3, Rod1 and Rsp5 was
predicted. We found that Rog3 and Rod1 did physically in-
teract with Rsp5. We used lysates of cells overexpressing myc-
Rsp5, Rod1^HA, and HA^Rog3 in the co-immunoprecipita-
tion assay. When we used extracts of cells harboring CEN-
based plasmids, complex formation of Rsp5 with Rod1 or
Rog3 could not be observed (data not shown). The interaction
of these proteins may be transient, and therefore di⁄cult to
detect in intact cells at the endogenous level. In the co-immu-
noprecipitation assay, the mutations in the PY motifs of Rod1
and Rog3 caused reduction in their binding ability to Rsp5
(Figs. 2 and 3). Since the overexpression of Rod1 but not
Rod1QA conferred resistance not only to o-DNB but also to
CDNB (data not shown), another target of GS-conjugate,
these results suggested an involvement of Rsp5 and Rod1 in
the detoxi¢cation pathway of GS-conjugate. As Rsp5 plays
roles in protein degradation and transcription [4^6], we are
now investigating whether or not Rod1 and Rsp5 regulate the
ABC transporters involved in drug resistance.
We think that Rog3 and Rod1 are regulators rather than
substrates of Rsp5, since the amount of Rod1^HA is usually
the same level as that of Rod1QA^HA in wild-type cells trans-
formed by each plasmid (data not shown). Bul1 and Bul2, the
PY motif-containing proteins binding to Rsp5, may also be
regulators of Rsp5 [18]. Other hect-type ubiquitin ligases pos-
sessing WW domains may be regulated by PY motif-contain-
ing proteins.
The rog3 mutation was isolated as an exogenous suppressor
of the mck1 mds1 mutant, but the level of suppression was
weak. Further, the rod1 mutant did not suppress temperature
sensitivity of the mck1 mds1 mutant, and the degradation of
Rog1, which is regulated by Rsp5 and GSK-3, was not af-
fected by deletion of ROG3 and ROD1 genes (data not
shown). The mechanism as to how the rog3 mutation partially
suppressed the defect of the mck1 mds1 mutant was not elu-
cidated. Despite levels of their suppressive potentials to the
mck1 mds1 mutant, the drug resistance may be mainly regu-
lated by ROD1 rather than ROG3, as rod1 but not rog3 mu-
tants showed o-DNB sensitivity. These di¡erences between
ROD1 and ROG3 may be partly caused by di¡erences in ex-
pression levels of encoding proteins, since our preliminary
data indicated that the amount of Rog3 is much lower than
that of Rod1. It is also possible that these two genes share
some but not all functions.
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